Prolonged T-cell response during severe COVID-19 does not contribute to long COVID

FHS
July 10, 2023
1:14 am

Persistent immune activation and elevated cytokine levels were observed in patients with severe COVID-19, even months after recovery. However, the correlation between immune activation and long COVID symptoms appeared to be independent, suggesting other factors influencing disease severity.

3DHISTECH and Epredia open pathology innovation incubator to accelerate advancements in cancer diagnostics

Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in Japan), announce the opening of the Pathology

September 25, 2023

The problem with potential changes to the biosimilar regulatory framework

Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price

September 26, 2023

M&A: NextGen Healthcare Acquired by PE Firm for $1.8B

What You Should Know: – Thoma Bravo, a private equity software investment firm has acquired NextGen Healthcare, Inc, for over $1.8B in cash. – Under

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.